Bromide

Bromide

SCHEMBL16010201

CCCC[P+](CCCC)(CCCC)CCCCC(CCC(=O)OCC)(OCC)OCC.[Br-]

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.37
CYP3A4 P08684 1/20 0.37
TSHR P16473 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
DNM1 Q05193 2/20 0.37
CYP1A2 P05177 1/20 0.36
KMT2A Q03164 3/20 0.35
POLB P06746 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.33
CTSK P43235 1/20 0.33
GAA P10253 2/20 0.33
DGKA P23743 1/20 0.33
MAPT P10636 2/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
CYP4F2 P78329 1/20 0.31
CYP4A11 Q02928 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL187295 0.80 CYP1A2 (0.47) CYP3A4TSHRTDP1CYP1A2KMT2A
SCHEMBL21387 0.79 CYP4F2 (0.47) CYP3A4TSHRTDP1CYP1A2KMT2A
SCHEMBL14731557 0.78 CYP1A2 (0.41) CYP3A4TSHRTDP1CYP1A2KMT2A
SCHEMBL21830 0.78 CYP1A2 (0.44) CYP3A4TSHRTDP1CYP1A2KMT2A
Bromide SCHEMBL14722907 0.77 CYP1A2 (0.40) CYP3A4TSHRTDP1CYP1A2KMT2A
SCHEMBL27966367 0.76 CYP1A2 (0.42) CYP3A4TSHRTDP1CYP1A2KMT2A
SCHEMBL14731592 0.75 CYP1A2 (0.39) CYP3A4TSHRTDP1CYP1A2KMT2A
SCHEMBL16258586 0.74 CYP1A2 (0.41) TSHRCYP1A2KMT2APOLBL3MBTL1
Bromide SCHEMBL10929451 0.73 CYP1A2 (0.53) ATMCYP3A4TSHRTDP1CYP1A2
Bromide SCHEMBL16009832 0.72 ALOX5 (0.36) CYP3A4TSHRPOLBL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210300954-A1 IONIC TAGS FOR SYNTHESIS OF OLIGORIBONUCLEOTIDES THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIV (CA) 2021-09-30 US disclosed
US-11014948-B2 Ionic tags for synthesis of oligoribonucleotides THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2021-05-25 US disclosed
EP-2748176-B1 IONIC TAGS FOR SYNTHESIS OF OLIGORIBONUCLEOTIDES THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING / MCGILL UNIV (CA) 2019-04-17 EP disclosed
US-9920084-B2 Ionic tags for synthesis of oligoribonucleotides THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2018-03-20 US disclosed
US-20140256926-A1 Ionic Tags for Synthesis of Oligoribonucleotides HONG KONG POLYTECHNIC UNIVERSITY (HK) 2014-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11014948-B2 Ionic tags for synthesis of oligoribonucleotides RNGTT, OSTC, DTYMK ATM 4479/4885CYP3A4 4700/4885TSHR 2662/4885
US-20210300954-A1 IONIC TAGS FOR SYNTHESIS OF OLIGORIBONUCLEOTIDES RNGTT, OSTC, DTYMK ATM 4479/4885CYP3A4 4700/4885TSHR 2662/4885
US-20140256926-A1 Ionic Tags for Synthesis of Oligoribonucleotides RNGTT, OSTC, OSGEP ATM 4439/4885CYP3A4 4723/4885TSHR 2718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.